Unbiased AI-powered news
3 stories related to this topic, newest first.
Simcere Pharmaceutical Group Limited entered a collaboration agreement with Stanford Medicine on May 29, 2026, to fund early-stage research on a potential treatment for idiopathic pulmonary fibrosis. The company will provide funding and, if the study succeeds, will license the mo…
Researchers found that deleting the Tlr5 gene in mice increased lung fibrosis after injury. A study published in Science Translational Medicine links the receptor to lung microbiome balance and disease progression.
benzinga.comMiNK Therapeutics presented clinical data at the ASGCT 2026 meeting showing its off-the-shelf iNKT cell therapy agenT-797 drove different immune responses in patients with solid tumors and those with acute respiratory distress syndrome. The same product batch from one donor activ…